DrRamon Bautista

Avalon Intensive Outpatient Program

ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CARISBAMATE (YKP509) AS ADJUNCTIVE TREATMENT FOR SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME IN CHILDREN AND ADULTS, WITH OPTIONAL OPEN-LABEL EXTENSION

CTOA

A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epilepsy with a Predictable Seizure Pattern

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety, and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy”, Protocol No. 101EP201

2017 Epilepsy Wellness Center of Excellence

Jessie Ball DuPont Religious, Charitable and Educational Fund grant to implement a coping and self-management course for epilepsy patients

SK Life Epilepsy PK study.

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE RESPONSE TRIAL OF YKP3089 AS ADJUNCTIVE THERAPY.....

AN EXTENDED ACCESS PROGRAM FOR PERAMPANEL

EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093)ASADJUNCTIVE THERAPY FOR REFRACTORY PARTIAL SEIZURES IN A.....

A MULTICENTER, OPEN-LABEL, LONG-TERM, SAFETY, TOLERABILITY AND EFFICACY STUDY OF RETIGABINE IN ADULT EPILEPSY PATIENTS W